0001213900-19-014041.txt : 20190730 0001213900-19-014041.hdr.sgml : 20190730 20190730170712 ACCESSION NUMBER: 0001213900-19-014041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190729 FILED AS OF DATE: 20190730 DATE AS OF CHANGE: 20190730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Paul Edward CENTRAL INDEX KEY: 0001658544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55347 FILM NUMBER: 19986338 MAIL ADDRESS: STREET 1: 300 EAST 56TH STREET, APT 19E CITY: NEW YORK, STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646 876 3459 MAIL ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 4 1 ownership.xml X0306 4 2019-07-29 0 0001553643 RELMADA THERAPEUTICS, INC. RLMD 0001658544 Kelly Paul Edward C/O RELMADA THERAPEUTICS, INC. 880 THIRD AVENUE, 12TH FLOOR NEW YORK, NY 10022 1 0 0 0 Options to purchase common stock 2.20 2019-07-29 4 A 0 600000 2.20 A 2029-07-29 Common Stock 600000 600000 D Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant. /s/ Paul E. Kelly 2019-07-30